Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute–Designated Cancer Program We distributed a 21-item survey on cancer screening ...
Alternative model to deliver germline genetic testing to patients with advanced prostate cancer (PCa). This is an ASCO Meeting Abstract from the 2023 ASCO Quality Care Symposium. This abstract does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results